Ethische Aspekte der medikamentösen Behandlung dementer Patienten

Ethik in der Medizin 15 (1):7-14 (2002)
  Copy   BIBTEX

Abstract

Definition of the problem: The development and use of drugs aimed at a positive influence on the cognitive decline in patients suffering from Alzheimer's disease raises a number of ethical issues. Arguments: Among other things, these issues are concerned with the significance of these drugs for the patient's subjective well-being and quality of life and with aspects of informed consent to the use of these drugs, particularly in connection with their use in scientific medical research. Conclusion: The value and significance of antidementia drugs depends not only on their effect on cognitive decline, but also on their wider significance for patients' quality of life and their primary carers. The subjective experience of those directly involved deserves more attention in research and practice

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 94,549

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Cognitive Enhancing Drugs.Charlotte R. Housden, Sharon Morein-Zamir & Barbara J. Sahakian - 2011 - In Julian Savulescu, Ruud ter Meulen & Guy Kahane (eds.), Enhancing Human Capacities. Blackwell. pp. 113–126.
Ethical issues in psychopharmacology.L. McHenry - 2006 - Journal of Medical Ethics 32 (7):405-410.

Analytics

Added to PP
2013-11-24

Downloads
20 (#776,057)

6 months
3 (#1,254,886)

Historical graph of downloads
How can I increase my downloads?